Stella M. Robertson

Dr. Robertson has over 25 years of experience in pharmaceutical research and global product development, including R&D strategies, project management, clinical trials, regulatory filings, market support, and medical communication. Stella is a co-founder of Bios Partners, LP, a member of the Cowtown Angels, and the founder of Arrochar Consulting LLC, specializing in due diligence, translational research, product development, and the life sciences. She volunteers with the incubator TECH Fort Worth, the UNTHSC entrepreneurial program, and as an adjunct for the Ophthalmology Department at UT Southwestern. She formerly was a Vice President of Research and Development at Alcon Laboratories, Inc., a Division of Novartis, where she grew and led organizations responsible for the ophthalmic pipeline. During her tenure at Alcon, she and her colleagues successfully developed, registered, and globally launched 16 ophthalmic medications, as well as treatments for otitis media and nasal allergy. In addition to Trefoil, she serves on the board of three Bios Partners portfolio companies, Azitra, Inc. (member), Lantern Pharma, Inc. (observer), Lung Therapeutics, Inc. (observer), and also as a member of the ARVO Foundation Board, the Cowtown Angels steering committee, and the AyuVis Research, Inc. board. Stella is an immunologist-cell biologist by training. She received a Ph.D. from Johns Hopkins University. She was an Arthritis Foundation post-doctoral research fellow at the UTHSC in Dallas, TX, and completed the Executive Program for Management Development at Harvard Business School.